EBUS-TBNA found safe and effective
An interview with Daniel Culver, DO
Younger patients respond better to endothelin receptor blockers
Findings from ADHERE registry should help guide patient selection
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Making lung transplant an option in complex cases
Creating a sleep biophysiologic repository, and studying OSA/QT prolongation links
When conventional ventilatory therapies aren’t enough
New tools to teach an old procedure
Three clinical trials testing old and new drugs
Acclaimed clinician, researcher and educator
Advertisement
Advertisement